|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:dateCreated |
2011-1-20
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
The feasibility of conducting a large-scale Polypill clinical trial in developing countries remains unclear. More information is needed regarding the efficacy in reducing the risk factors of cardiovascular disease (CVD), side effects, improvement in adherence and physician/patient "acceptability" of the Polypill.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin-Converting Enzyme...,
http://linkedlifedata.com/resource/pubmed/chemical/Aspirin,
http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers,
http://linkedlifedata.com/resource/pubmed/chemical/Cardiovascular Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol,
http://linkedlifedata.com/resource/pubmed/chemical/Diuretics,
http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations,
http://linkedlifedata.com/resource/pubmed/chemical/Hydrochlorothiazide,
http://linkedlifedata.com/resource/pubmed/chemical/Hydroxymethylglutaryl-CoA...,
http://linkedlifedata.com/resource/pubmed/chemical/Lisinopril,
http://linkedlifedata.com/resource/pubmed/chemical/Platelet Aggregation Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Simvastatin
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1745-6215
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3
|
|
pubmed:dateRevised |
2011-7-20
|
|
pubmed:meshHeading |
pubmed-meshheading:21205325-Aged,
pubmed-meshheading:21205325-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:21205325-Aspirin,
pubmed-meshheading:21205325-Attitude of Health Personnel,
pubmed-meshheading:21205325-Biological Markers,
pubmed-meshheading:21205325-Blood Pressure,
pubmed-meshheading:21205325-Cardiovascular Agents,
pubmed-meshheading:21205325-Cardiovascular Diseases,
pubmed-meshheading:21205325-Chi-Square Distribution,
pubmed-meshheading:21205325-Cholesterol,
pubmed-meshheading:21205325-Diuretics,
pubmed-meshheading:21205325-Drug Combinations,
pubmed-meshheading:21205325-Feasibility Studies,
pubmed-meshheading:21205325-Female,
pubmed-meshheading:21205325-Health Knowledge, Attitudes, Practice,
pubmed-meshheading:21205325-Humans,
pubmed-meshheading:21205325-Hydrochlorothiazide,
pubmed-meshheading:21205325-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:21205325-Lisinopril,
pubmed-meshheading:21205325-Male,
pubmed-meshheading:21205325-Medication Adherence,
pubmed-meshheading:21205325-Middle Aged,
pubmed-meshheading:21205325-Platelet Aggregation Inhibitors,
pubmed-meshheading:21205325-Primary Prevention,
pubmed-meshheading:21205325-Questionnaires,
pubmed-meshheading:21205325-Risk Assessment,
pubmed-meshheading:21205325-Risk Factors,
pubmed-meshheading:21205325-Simvastatin,
pubmed-meshheading:21205325-Sri Lanka,
pubmed-meshheading:21205325-Time Factors,
pubmed-meshheading:21205325-Treatment Outcome,
pubmed-meshheading:21205325-World Health Organization
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
A Polypill for primary prevention of cardiovascular disease: a feasibility study of the World Health Organization.
|
|
pubmed:affiliation |
Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
